Header cover image

Japanese (NIKKEI) Healthcare Sector Analysis

UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies199
  • 7D-3.1%
  • 3M-5.2%
  • 1Y1.8%
  • YTD2.2%

Over the last 7 days, the Healthcare industry has dropped 3.1%, driven by a pullback from Daiichi Sankyo Company of 6.3%. Meanwhile, M3 actually outperformed within the industry, gaining 5.2% in the last week. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 13% annually.

Sector Valuation and Performance

Has the Japanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 03 Feb 2023JP¥59.1tJP¥32.6tJP¥2.2t16x26.4x1.8x
Sun, 01 Jan 2023JP¥60.0tJP¥32.4tJP¥2.2t16x27.6x1.9x
Tue, 29 Nov 2022JP¥65.0tJP¥32.4tJP¥2.2t16.5x29.9x2x
Thu, 27 Oct 2022JP¥64.2tJP¥31.7tJP¥2.2t15.6x28.6x2x
Sat, 24 Sep 2022JP¥60.4tJP¥31.7tJP¥2.3t15.6x26.7x1.9x
Mon, 22 Aug 2022JP¥63.5tJP¥31.7tJP¥2.3t16x28x2x
Wed, 20 Jul 2022JP¥61.7tJP¥31.3tJP¥2.3t16.2x26.7x2x
Fri, 17 Jun 2022JP¥55.5tJP¥31.3tJP¥2.3t15.4x24x1.8x
Sun, 15 May 2022JP¥57.6tJP¥31.3tJP¥2.3t15.4x25.1x1.8x
Tue, 12 Apr 2022JP¥60.0tJP¥30.8tJP¥2.4t17.4x25.1x2x
Thu, 10 Mar 2022JP¥54.1tJP¥30.8tJP¥2.4t14.9x22.6x1.8x
Sat, 05 Feb 2022JP¥58.7tJP¥30.6tJP¥2.4t16.8x24.3x1.9x
Mon, 03 Jan 2022JP¥63.9tJP¥30.3tJP¥2.4t17.6x26.4x2.1x
Wed, 01 Dec 2021JP¥64.2tJP¥30.3tJP¥2.4t9.7x26.5x2.1x
Fri, 29 Oct 2021JP¥66.6tJP¥29.9tJP¥2.3t20.3x29x2.2x
Sun, 26 Sep 2021JP¥72.1tJP¥29.4tJP¥2.2t22x32.4x2.5x
Tue, 24 Aug 2021JP¥66.9tJP¥29.5tJP¥2.2t20.3x30.1x2.3x
Wed, 30 Jun 2021JP¥67.0tJP¥29.5tJP¥2.2t21.1x30.1x2.3x
Sat, 03 Apr 2021JP¥66.4tJP¥28.7tJP¥2.0t22.2x32.8x2.3x
Tue, 05 Jan 2021JP¥69.4tJP¥28.6tJP¥1.8t22.9x37.7x2.4x
Fri, 09 Oct 2020JP¥64.7tJP¥28.5tJP¥1.7t24.9x37.5x2.3x
Thu, 02 Jul 2020JP¥63.2tJP¥28.6tJP¥1.8t23.1x34.3x2.2x
Sun, 05 Apr 2020JP¥53.2tJP¥28.9tJP¥1.8t19.9x29.7x1.8x
Price to Earnings Ratio

31.5x


Total Market Cap: JP¥58.3tTotal Earnings: JP¥1.9tTotal Revenue: JP¥28.7tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Healthcare Sector Price to Earnings3Y Average 30.2x202120222023
Current Industry PE
  • Investors are pessimistic on the Japanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 26.4x which is lower than its 3-year average PE of 30.2x.
  • The 3-year average PS ratio of 2.1x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 6.5% per year over the last three years.
  • Revenues for these companies have grown 4.4% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare sector?

JP Market-0.51%
Healthcare-3.11%
Healthtech1.42%
Healthcare Services0.13%
Life Sciences-0.013%
Biotech-0.64%
Medical Equipment-2.25%
Pharma-4.23%
Industry PE
  • Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 98.7x.
    • Analysts are expecting annual earnings growth of 19.1%, which is higher than its past year's earnings growth of 11.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 25% over the next 5 years.
  • This is better than its past earnings decline of 48% per year.
  • In contrast, the Life Sciences industry is expected to see its earnings grow by 3.0% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2413 M3JP¥3.72k5.2%
+JP¥125.6b
-14.4%PE53.6x
7733 OlympusJP¥2.47k2.8%
+JP¥83.4b
-4.2%PE24.4x
4502 Takeda PharmaceuticalJP¥4.17k0.9%
+JP¥57.5b
23.3%PE23.6x
4543 TerumoJP¥3.81k1.6%
+JP¥44.7b
-10.2%PE35.3x
6869 SysmexJP¥8.66k1.6%
+JP¥28.9b
-20.7%PE39.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4519

JP¥3,377.00

Chugai Pharmaceutical

7D

-1.9%

1Y

-15.2%

4502

JP¥4,171.00

Takeda Pharmaceutical

7D

0.9%

1Y

23.3%

4568

JP¥4,061.00

Daiichi Sankyo Company

7D

-6.3%

1Y

75.8%

7741

JP¥14,245.00

HOYA

7D

-0.9%

1Y

-7.2%

2395

JP¥2,498.00

Shin Nippon Biomedical Laboratories

7D

9.6%

1Y

51.0%

4528

JP¥2,809.50

Ono Pharmaceutical

7D

-3.3%

1Y

0.7%

4507

JP¥6,207.00

Shionogi

7D

-2.1%

1Y

-20.0%

4578

JP¥4,087.00

Otsuka Holdings

7D

-2.3%

1Y

0.7%

4523

JP¥7,869.00

Eisai

7D

-3.4%

1Y

36.7%

4503

JP¥1,889.50

Astellas Pharma

7D

-2.5%

1Y

-5.5%

7716

JP¥2,743.00

Nakanishi

7D

4.0%

1Y

31.6%

6869

JP¥8,656.00

Sysmex

7D

1.6%

1Y

-20.7%

7071

JP¥3,485.00

Amvis Holdings

7D

2.3%

1Y

68.8%

7733

JP¥2,471.00

Olympus

7D

2.8%

1Y

-4.2%

2413

JP¥3,720.00

M3

7D

5.2%

1Y

-14.4%

4543

JP¥3,814.00

Terumo

7D

1.6%

1Y

-10.2%